Endocan Blood Level in Pulmonary Circulation

NCT04616820 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2021-02-05

No results posted yet for this study

Summary

Endocan is a proteoglycan produced by the vascular endothelium. Animal studies suggested that the synthesis mainly happen in the pulmonary circulation, but this hypothesis has never been confirmed in humans.

Conditions

  • Cardiac Surgery
  • Cardiopulmonary Bypass
  • Lung

Sponsors & Collaborators

  • Biothelis

    collaborator UNKNOWN
  • Centre Hospitalier Universitaire de Besancon

    lead OTHER

Principal Investigators

  • Pascal DEBAT · CHU Jean Minjoz Besançon

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-31
Primary Completion
2021-06-30
Completion
2021-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04616820 on ClinicalTrials.gov